Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Biotest 988: A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human) Civacir in Orthotopic Liver Transplant Recipients
Rosenau, Jens
(PI)
Daily, Michael
(CoI)
Gedaly, Roberto
(CoI)
Rojas, Hender
(CoI)
Shah, Malay
(CoI)
Sitzlar, Stephen
(CoI)
Surgery
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
6/20/13
→
6/30/17
Funding
Biotest Pharmaceuticals Corporation:
$162,875.00
View all
View less